Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Exercise/Conversion of 125,000 CADL shares, $193.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Candel Therapeutics, Inc. (CADL) | Exercise/Conversion | 125,000 | $193.8K |
| Jan 28, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 629,000 | n/a |
| Jun 26, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 42,826 | $200.0K |
| Mar 20, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 25,772 | $226.0K |
| Feb 14, 2025 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 525,000 | n/a |
| Jan 17, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 21,704 | $156.8K |
| Jan 10, 2025 | Candel Therapeutics, Inc. (CADL) | Sale | 21,172 | $174.0K |
| Dec 3, 2024 | Candel Therapeutics, Inc. (CADL) | Sale | 48,847 | $222.5K |
| Nov 21, 2024 | Candel Therapeutics, Inc. (CADL) | Exercise/Conversion | 12,900 | $20.0K |
| Jul 19, 2024 | Candel Therapeutics, Inc. (CADL) | Sale | 22,528 | $145.8K |